January 19, 2021
Article
A look into the numerous education series upcoming in 2021 by the Tuberous Sclerosis Alliance
July 02, 2019
Slideshow
What does compensation for neurologists look like these days? Would you choose neurology all over again?
June 07, 2019
Article
Emgality (galcanezumab-gnlm) is the first FDA-approved drug that reduces the frequency of headache attacks.
April 18, 2019
Article
Chronic pain, sleep disorders, neuropathy, and anxiety were the most common conditions that showed improvement in the study.
October 25, 2017
Article
Do you want to make your voice heard? Then join the Neurology Times Advisory Board!
October 23, 2017
Article
If you could bring only one book or film with you to a desert island, what would it be?
September 13, 2017
Article
If your patient manifests signs that are compatible with Alzheimer disease, should you recommend olive oil as part of a prevention and treatment regimen? This and other questions answered by Domenico Pratico, MD.
October 06, 2014
Article
This infographic spotlights the most common unexpected claim denials in medicine nationwide, with a special focus on neurology.
Serum Neurofilament Light Poses as Critical Biomarker During Ataxic, Preataxic Stages of Spinocerebellar Ataxias
Connecting ALS: How New Drug Coverage Decisions Are Made
NeuroVoices: Mark Lew, MD, on the Validation of Tears as a Biomarker for Parkinson Disease
AlzoSure Predict Test Shows Predictive Ability for Alzheimer Disease Years Prior to Diagnosis